NexgenRx processes drug and dental claims for Canadian employers and charges a small fee every time a claim runs through their platform.

Q1 2026 net income: $1.23M. Full year 2025 net income: $1.29M.

Revenue up 12% YoY while total expenses actually fell.

The growth is being driven by Patient Support Programs, where drug manufacturers enroll patients and every claim runs through NXG's platform at a fee. That volume has been accelerating for multiple years.

They are basically Canada's only independent full-service third-party administrator in this space. The big insurers outsource claims adjudication, and NXG sits in that gap.

Profitable. Growing. Zero debt. Pays a dividend.

$30M market cap on a business doing nearly $18M in annual revenue and growing.

If Q1 pace holds, they could do $4-5M in net income in 2026 alone.

Insiders own 37% of shares.

Not financial advice in the slightest.